Historique
Périodique
Dual Pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients
(Double pharmacothérapie combinée avec une thérapie motivationnelle pour le traitement de la dépendance tabagique.)
Auteur(s) :
RICHTER, K. P. ;
McCOOL, R. M. ;
CATLEY D. ;
HALL, M. ;
AHLUWALIA, J. S.
Année
2005
Page(s) :
79-90
Langue(s) :
Anglais
Refs biblio. :
18
Domaine :
Tabac / Tobacco / e-cigarette
Thésaurus mots-clés
TABAC
;
ENTRETIEN MOTIVATIONNEL
;
PHARMACOTHERAPIE
;
THERAPIE COMPORTEMENTALE
;
MOTIVATION
;
DEPENDANCE
;
EFFICACITE
Note générale :
Journal of Addictive Diseases, 2005, 24, (4), 79-90
Note de contenu :
fig.
Résumé :
ENGLISH :
This pilot study is the first to examine the feasibility and outcomes of dual pharmacotherapy for smoking cessation among drug treatment patients. The intervention consisted of 7 weeks of bupropion (300 mg), 12 weeks of nicotine gum, and 6 sessions of motivational interviewing. The trial was conducted among 28 patients recruited from 5 methadone clinics and employed a pretest-posttest design. At 6 months post quit date, 14% of participants met criteria for biochemically-verified abstinence. Among those still smoking, number of cigarettes smoked decreased significantly and most (88%) had made at least 1 serious quit attempt. Participation rates were excellent and no adverse effects on alcohol or illicit drug use were found. Although not a definitive test of the intervention, findings suggest that a multi-component approach to tobacco dependence is feasible and potentially effective in helping drug treatment patients achieve smoking cessation well beyond the end of treatment and that a large-scale randomized trial is warranted. (Author' s abstract)
Affiliation :
Dept of Preventive Medicine and Public Health, Mail-Stop 1008, Univ. Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160. E-mail: krichterkumc.edu
Etats-Unis. United States.
Etats-Unis. United States.